Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Double-blind, Randomized-controlled Trial Using a Low Dose of Ketamine vs. Active Placebo in Treating Severe Depression and Suicide

To see complete record on, please visit this link

Id: NCT03666390

Organisation Name: Taipei Veterans General Hospital, Taiwan

Overal Status: Unknown status

Start Date: September 10, 2018

Last Update: September 19, 2018

Lead Sponsor: Taipei Veterans General Hospital, Taiwan

Brief Summary: Depression and suicide are two leading mental health and public health issues in Taiwan. However, until now, the optimal treatment for refractory depression and suicide is still lacking. Previous USA studies suggested a low dose NMDA antagonist Ketamine infusion can significantly reduce depression and suicide. In our study, we firstly investigate the anti-suicide and anti-depressive effects of ketamine in Taiwan. If we can find the similar antidepressant and anti-suicide of ketamine in Taiwanese, this result will have a great influence in the current suicide and depression prevention programs.

  • Major Depressive Disorder

Total execution time in seconds: 0.20235586166382